SS
CERO

SBI Securities’s CERo Therapeutics CERO Stock Holding History

SBI Securities’s Portfolio CERO Stock Details CERO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18
Closed -$92 – 4259
2025
Q3 		$92 Hold
18
– – ﹤0.01% 3540
2025
Q2 		$173 Buy
18
+12
+200% +$149 ﹤0.01% 3363
2025
Q1 		$80 Buy
6
+3
+100% +$119 ﹤0.01% 3521
2024
Q4 		$331 Buy
+3
New +$699 ﹤0.01% 3045

SBI Securities's CERO Position: Q4 2025 in Review

SBI Securities sold out of CERo Therapeutics (CERO) in Q4 2025, closing a stake of 18 shares — an estimated $92 sold.

SBI Securities first reported a position in CERO in Q4 2024 and held it in 4 quarters. The position peaked at $331 in Q4 2024. 0 funds tracked by Wall St. Rank hold CERO as of Q4 2025.

  • SBI Securities reported no remaining CERo Therapeutics position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 18 CERo Therapeutics shares in Q4 2025, an estimated $92.
  • SBI Securities first reported a position in CERo Therapeutics in Q4 2024 and held it in 4 quarters.
  • SBI Securities's CERo Therapeutics position peaked at $331 in Q4 2024.
  • 0 funds tracked by Wall St. Rank held CERo Therapeutics as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.